Home
Who we are
Pipeline
News
Contact
Our mission is to develop essential medicines to improve
care and support of pediatric orphan diseases.
ORPHELIA Pharma
is a biopharmaceutical company dedicated to the development and marketing of pediatric drugs in oncology and neurology.
Latest news and reports
Latest news and report
29 octobre 2019
ORPHELIA Pharma will be present at CPhI in Frankfurt
Read more
29 octobre 2019
License and distribution agreement for Kigabeq in the United Kingdom
Read more
22 octobre 2019
ORPHELIA at the Rare Diseases Meeting Days
Read more
16 octobre 2019
ORPHELIA at the annual SIOP Congress
Read more
15 octobre 2019
Dr. Caroline Lemarchand appointed Chief Pharmaceutical Development Officer
Read more
30 septembre 2019
CHMP has adopted a positive opinion for Ivozall®
Read more
9 septembre 2019
ORPHELIA at the XIIth National Oncology Days of the French Society of Pharmacy Oncology
Read more
3 septembre 2019
Orphan Drug Designation granted for temozolomide in the treatment of neuroblastoma
Read more
